This past week, the Enzolytics (OTCMKTS:ENZC) stock was one of the more impressive performers.
On Friday, the stock was in focus yet again and jumped by 27% to take its gains for the week to as much as 77%. The stock has been in focus among many investors this week primarily due to a key announcement from the company on May 26 about a key discovery. The company had announced that it had discovered immutable sites on the HTVL-1 virus.
It goes without saying that it is a major breakthrough for Enzolytics since it is now going to start working on monoclonal antibodies that could combat the HTVL-1 virus. More importantly, it presents a big opportunity since at this point there are no effective vaccines for HTVL-1 virus infection. Hence, it did not come as a surprise that the stock has rallied strongly following the announcement. It now remains to be seen if the Enzolytics stock can continue to hold on to its momentum this coming week.
Key Performances
| 5-DAY PERF. | +75.79% |
| 1-MONTH PERF. | +75.38% |
| 3-MONTH PERF. | -13.64% |
| 6-MONTH PERF. | +204.00% |
| YTD PERF. | +190.45% |
| 1-YEAR PERF. | +56900.00% |
Pivot Points
| Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
| Classic | 0.1447 | 0.1613 | 0.1947 | 0.2113 | 0.2447 | 0.2613 | 0.2947 |
| Fibonacci | 0.1613 | 0.1804 | 0.1922 | 0.2113 | 0.2304 | 0.2422 | 0.2613 |
 stock Hits 2-Month High: Is The Rally Real?){kind=link}